Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Central Nervous System Neoplasms 20Brain Neoplasms 12Medulloblastoma 8Meningeal Carcinomatosis 6Rhabdoid Tumor 5Lymphoma 5Choroid Plexus Neoplasms 5Astrocytoma 5Neuroblastoma 4Ependymoma 4Breast Neoplasms 4Sarcoma 3Oligodendroglioma 3Lymphoma, Non-Hodgkin 2Gliosarcoma 2Glioblastoma 2Waldenstrom Macroglobulinemia 1Spinal Cord Neoplasms 1Sezary Syndrome 1Retinoblastoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Ototoxicity 1Osteosarcoma 1Neurotoxicity Syndromes 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors, Primitive 1

Interventions

Zidovudine 1Methotrexate 1Leucovorin 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
AIDS-Related Opportunistic Infections × Methotrexate × CNS × Clear all
NCT00000723 2021-10-28

The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer

National Institute of Allergy and Infectious Diseases (NIAID)

Phase NA Terminated
45 enrolled
CNSLymphoid

Acquired Immunodeficiency Syndrome, Brain Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, HIV Infections, AIDS-Related Opportunistic Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡